Sarah B. Kavanagh
CIK: 0001681171
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 26, 2026BLCO
Bausch & Lomb Corp
Award(A)Direct15.8K shares at avg. $15.78$250K - May 22, 2026BHC
Bausch Health Companies Inc.
Award(A)Direct45.9K shares- - May 27, 2025BLCO
Bausch & Lomb Corp
Award(A)Direct20.3K shares- - May 16, 2025BHC
Bausch Health Companies Inc.
Award(A)Direct54.3K shares-
1-4 of 4 transactions
About KAVANAGH SARAH B
KAVANAGH SARAH B (SEC CIK 0001681171) files insider reports with the SEC as Director of Bausch & Lomb Corp (BLCO) and Director of Bausch Health Companies Inc. (BHC).
Signal8 holds 4 ownership filings by KAVANAGH SARAH B, all Form 4s, filed between May 20, 2025 and May 28, 2026. Those filings report 4 transactions, from May 16, 2025 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KAVANAGH SARAH B's filings is in BRIDGEWATER, NJ.
Recent filings by KAVANAGH SARAH B
Other insiders filing for Bausch & Lomb Corp (BLCO)
- Munsch Frederick, SVP, Controller and CAO
- ROBERTSON RUSSEL C, Director
- Paulson John, Director
- Alfonso Eduardo, Director
- Trebbi Barbara, Director
- PAUL LAURENCE E, Director